A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales ...

Henry Schein is up 3.2% since the beginning of the year, but at $70.76 per share, it is still trading 13.6% below its 52-week high of $81.91 from February 2025. Investors who bought $1,000 worth ...

Henry Schein reaffirmed its adjusted annual profit forecast of $4.80 to $4.94 per share, compared with analysts' average estimate of $4.86 per share, according to data compiled by LSEG.

Henry Schein (HSIC) stock drops as Stifel downgrades the company to Hold, citing market share losses to online vendors in dental consumables. Read more here.

In the assessment of 12-month price targets, analysts unveil insights for Henry Schein, presenting an average target of $77.17, a high estimate of $86.00, and a low estimate of $72.00.

Feb 25 (Reuters) - Henry Schein (HSIC.O) forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid persistent inflation.

On Feb. 25, Henry Schein reported its fourth-quarter results, posting a 5.8% year-over-year revenue increase to $3.2 billion, fueled by strong growth in dental and medical distribution.